PRAXIS PRECISION MEDICINES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.16 USD | +2.09% |
|
-6.62% | +104.44% |
Presenter SpeechNeena Bitritto-Garg (Analysts)So, good morning, everyone, and thank you for at...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.
Calendar
2024-06-05
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
45.21
USD
Average target price
135
USD
Spread / Average Target
+198.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +104.44% | 773M | |
| +34.11% | 50.85B | |
| +0.70% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +10.95% | 26.11B | |
| -21.55% | 19.13B | |
| +9.29% | 13.05B | |
| +27.02% | 12.16B | |
| +23.96% | 12.08B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Transcript : Praxis Precision Medicines, Inc. Presents at Citi’s 16th Annual BioPharma Virtual Conference, Sep-08-2021 10